Diuretics. I. Physiological and pharmacological considerations.
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000584:Amiloride / Q000494:pharmacology; D001581:Benzothiadiazines / Q000494:pharmacology; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology*; D004976:Ethacrynic Acid / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D005919:Glomerular Filtration Rate; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D007671:Kidney Concentrating Ability / Q000187:drug effects; D007684:Kidney Tubules / Q000187:drug effects / Q000502:physiology; D008353:Mannitol / Q000494:pharmacology; D009941:Organomercury Compounds / Q000494:pharmacology; D009995:Osmosis / Q000187:drug effects; D013148:Spironolactone / Q000494:pharmacology; D014223:Triamterene / Q000494:pharmacology; D014882:Water-Electrolyte Balance / Q000187:drug effects; D014970:Xanthines / Q000494:pharmacology
D001581:Benzothiadiazines; D002257:Carbonic Anhydrase Inhibitors; D004232:Diuretics; D009941:Organomercury Compounds; D014970:Xanthines; D013148:Spironolactone; D008353:Mannitol; D000584:Amiloride; D005665:Furosemide; D004976:Ethacrynic Acid; D014223:Triamterene